Armodafinil 250 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FZ9W2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,650
Award facts
- Contract value 100% obligated
- $5,649.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $5,649.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on November 3, 2025, with completion scheduled for November 4, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Armodafinil, a wakefulness-promoting agent commonly used for fatigue management in military and federal healthcare settings, will be distributed through DLA's Medical Supply Chain to support defense and veteran healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to meet federal procurement requirements through competitive awards across diverse pharmaceutical and medical supply categories. The company's SPE2DX master contract serves as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical vendor within the DLA's medical supply chain, supporting operational readiness and healthcare delivery across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FZ9W2?
SPE2DR26FZ9W2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FZ9W2 worth?
The government has obligated $5,650 on SPE2DR26FZ9W2.
Is contract SPE2DR26FZ9W2 an order under another contract?
Yes. SPE2DR26FZ9W2 is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FZ9W2 competed?
The extent of competition for SPE2DR26FZ9W2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award